Categories : Hematology
Product Packaging : 2 ml
Product Composition : 125 mg/ml, 250 mg/2 ml
Send MessageEtamsylate Injection is a haemostatic agent used to prevent and control capillary bleeding associated with various surgical, gynecological, and medical conditions. The medicine works by improving platelet adhesion and enhancing capillary endothelial stability, thereby reducing abnormal bleeding without affecting the normal coagulation process. Genliva Wellness LLP is a trusted Etamsylate Injection Manufacturer in India offering high-quality hospital and critical care injectable formulations for domestic and international pharmaceutical markets.
Etamsylate is widely utilized in clinical practice for the management of bleeding disorders and excessive blood loss related to surgical interventions. Its action on capillary resistance and platelet function makes it a valuable therapeutic option in situations where effective bleeding control is required. As a reliable Etamsylate Injection Exporter from India, Genliva Wellness LLP supplies quality-assured injectable products to healthcare institutions and pharmaceutical distributors worldwide.
Etamsylate Injection plays an important role in haemostatic management and is commonly incorporated into treatment protocols aimed at minimizing blood loss and supporting vascular integrity.
Etamsylate Injection is formulated to promote haemostasis and reduce capillary bleeding.
Etamsylate Injection is used in the prevention and management of bleeding conditions.
Etamsylate Injection provides effective haemostatic support in bleeding-related conditions.